Prof. Shen Lin
Chief Physician · Professor
Academic Profile
Professor Shen Lin is Director of GI Medical Oncology at Peking University Cancer Hospital and the academic leader of GI medical oncology in China. The precision-treatment and clinical-research systems she built for advanced gastric and esophageal cancers have made China a major pole of global GI oncology research.
She has led hundreds of multicenter studies covering HER2, CLDN18.2, PD-1 and other targets, continuously improving survival outcomes for patients with advanced GI tumors.
Appointments & Honors
- Vice President, CSCO
- Founder, Chinese Gastrointestinal Oncology Group (CGOG)
- Core author of China’s gastric cancer diagnosis & treatment guidelines
Appointments
- Director, GI Medical Oncology, Peking University Cancer Hospital
- Chair, Chemotherapy Committee, CACA
- Chair, CSCO Gastric Cancer Committee
Areas of Expertise
- Precision therapy for advanced gastric cancer
- Comprehensive care for esophageal cancer
- Clinical research of novel agents in GI tumors
Academic Achievements
- Led pivotal China studies of CLDN18.2 and HER2-targeted agents
- A principal drafter of China’s advanced gastric cancer standards
- Research published in Lancet Oncology, JCO and other journals
Selected Publications
Sintilimab plus chemotherapy for unresectable gastric or gastroesophageal junction cancer (ORIENT-16)
JAMA · 2023
Corresponding author
CSCO guidelines for the diagnosis and treatment of gastric cancer
CSCO 指南工作委员会
Editor-in-chief
Cancer Focus
Medical GI Oncology
Outpatient Schedule
| Mon AM · Specialist Clinic |
| Wed PM · VIP Clinic |
Schedules sync with the hospital’s official website daily at 00:00 CST. Actual availability is subject to the hospital’s same-day announcement.
Available Hospitals
CASE FEASIBILITY REVIEW
Submit Your Case for a Free Review
Share your contact details, confirmed diagnosis and main question. No medical files needed at this stage. A clinical coordinator will contact you within 24-48 hours.
- No medical file upload required at this stage
- By submitting you agree to our privacy policy. Your information is used solely for hospital assessment and transmitted encrypted.